|
Shilpa Medicare announced another first time in the world Oral Thin Film
formulation, a pediatric dose Paracetamol Oral Thin Film, under the Brand
name Molshil®.
Shilpa received approval for Molshil® Oral Thin Films after sufficiently
complying bioequivalence requirements.
Shilpa's Paracetamol Oral Thin Films are patent protected and are first of
this kind in the world.
The new presentation of Paracetamol from Shilpa will have benefits of easy administration, excellent palatability and overcome disadvantages of
presently available pediatric formulations like dose variation, sedimentation or poor suspendability, presence of alcohol, messy and crystallized bottles in usage, fragile glass bottles etc.
|